Principia Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRNB and buy or sell other stocks, ETFs, and their options commission-free!About PRNB
Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill.
CEOMartin Babler
CEOMartin Babler
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2008
Founded2008
Employees—
Employees—
PRNB Key Statistics
Market cap3.32B
Market cap3.32B
Price-Earnings ratio-41.60
Price-Earnings ratio-41.60
Dividend yield—
Dividend yield—
Average volume793.58K
Average volume793.58K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$101.89
52 Week high$101.89
52 Week low$25.35
52 Week low$25.35
People also own
Based on the portfolios of people who own PRNB. This list is generated using Robinhood data, and it’s not a recommendation.